Results 71 to 80 of about 2,727 (172)

Relugolix, Estradiol, and Norethindrone Acetate

American Journal of Health-System Pharmacy, 2021
openaire   +2 more sources

The effect of low-dose combined hormone therapy (oestradiol and norethindrone acetate) on serum C-reactive protein levels and life quality in natural menopause women

Menopause Review, 2021
Servin Gocer, Suleyman Guven, Hidayet Sal, Emine Seda Guvendag Guven   +3 more
doaj   +1 more source

Norethindrone Acetate [PDF]

, 2020
openaire   +1 more source

Effect of Norethindrone Acetate on Masculinization, Growth and Reproduction in Zebrafish Danio rerio

Asian Fisheries Science, 2010
A. BALASUBRAMANI
doaj   +1 more source

Comparison of Dermatologic and Neuropsychological Side Effects of Oral Contraceptives, 2016-2020. [PDF]

Open Access J Contracept
Visingardi J, Feustel PJ, Flink-Bochacki R, Denefrio C.   +3 more
europepmc   +1 more source

Editorial: Utilizing real-world evidence for better endocrine health management. [PDF]

Front Endocrinol (Lausanne)
Mei M, Lopes LC, Li C.
europepmc   +1 more source

Brief Report: Exploratory Substudy of a Phase 2 Trial to Evaluate the Pharmacokinetic Effect of Once-Monthly Islatravir on Long-Acting Reversible Contraceptives. [PDF]

J Acquir Immune Defic Syndr
Pham M, Wickremasingha P, Vargo R, Patel M, Nedrow K, Homony B, Robertson MN, Plank RM.   +7 more
europepmc   +1 more source

Effect of Diethylstilbestrol and Norethindrone on Sex Ratio and Body Indices of Common Carp, Cyprinus carpio (Linn.)

Asian Fisheries Science, 2010
B. H. VINOD
doaj   +1 more source

Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084. [PDF]

J Int AIDS Soc
Marzinke MA, Hanscom B, Haines D, Scarsi KK, Agyei Y, Piwowar-Manning E, Hendrix CW, Gollings R, Rose S, Mathew C, Panchia R, Spooner E, Singh N, Bock P, Rinehart AR, Ford SL, Rooney JF, Soto-Torres L, Cohen MS, Hosseinipour MC, Delany-Moretlwe S, HPTN 084 Study Team.   +21 more
europepmc   +1 more source

Safety of 48 months of elagolix with add-back therapy for endometriosis-associated pain. [PDF]

AJOG Glob Rep
Kim JH, Miller CE, Simon JA, Thomas JW, Chan A, Snabes MC.   +5 more
europepmc   +1 more source